Rep. Abigail D. Spanberger (D-Va.) is one of six U.S. House members urging colleagues to sign a bipartisan letter to HHS leadership on 340B. | C-SPAN

Bipartisan U.S. House Members Corralling Last-Minute Signatures on 340B Letter to HHS

Today is the deadline for U.S. House members to sign a bipartisan letter asking U.S. Health and Human Services Department (HHS) leaders to act against drug manufacturers denying 340B pricing on drugs, to halt attempts to turn 340B into a rebate program, and to seat the 340B administrative dispute resolution board immediately and begin processing petitions. The original deadline was Feb. 11.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.